No-match ORESTES explored as tumor markers

Nucleic Acids Research

Volumn 37, Issue 8, 2009, Pages 2607-2617

  Mello, Barbara P ^a   Abrantes, Eduardo F ^a   Torres, César H ^a   Machado Lima, Ariane ^b   Fonseca, Rogério da Silva ^a   Carraro, Dirce M ^a   Brentani, Ricardo R ^a   Reis, Luiz F L ^a   Brentani, Helena ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RIBONUCLEASE; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE MAPPING; GENETIC DATABASE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

CHROMOSOME MAPPING; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RNA, NEOPLASM; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 65849357608     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp074     Document Type: Article

References (76)

1. Maxam,A.M. and Gilbert,W. (1977) A new method for sequencing DNA. Proc. Natl Acad. Sci. USA, 74, 560-564.
2. Sanger,F., Nicklen,S. and Coulson,A.R. (1992) DNA sequencing with chain-terminating inhibitors (classical article: 1977). Biotechnology 24, 104-108.
3. Brentani,H., Caballero,O.L., Camargo,A.A., da Silva,A.M., da,S.W.A. Jr, Dias,N.E., Grivet,M., Gruber,A., Guimaraes,P.E., Hide,W. et al. (2003) The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc. Natl Acad. Sci. USA, 100, 13418-13423.
4. Birney,E., Stamatoyannopoulos,J.A., Dutta,A., Guigo,R., Gingeras,T.R., Margulies,E.H., Weng,Z.P., Snyder,M., Dermitzakis,E.T., Thurman,R.E. et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447 799-816.
5. Carninci,P., Kasukawa,T., Katayama,S., Gough,J., Frith,M.C., Maeda,N., Oyama,R., Ravasi,T., Lenhard,B., Wells,C. et al. (2005) The transcriptional landscape of the mammalian genome. Science, 309 1559-1563.
6. Frith,M.C., Pheasant,M. and Mattick,J.S. (2005) The amazing complexity of the human transcriptome. Eur. J. Hum. Genet., 13, 894-897.
7. Katayama,S., Tomaru,Y., Kasukawa,T., Waki,K., Nakanishi,M., Nakamura,M., Nishida,H., Yap,C.C., Suzuki,M., Kawai,J. et al. (2005) Antisense transcription in the mammalian transcriptome. Science, 309, 1564-1566.
8. Mattick,J.S. and Makunin,I.V. (2006) Non-coding RNA. Hum. Mol. Genet. 15, R17-R29.
9. Mehler,M.F. and Mattick,J.S. (2006) Non-coding RNAs in the nervous system. J. Physiol., 575, 333-341.
10. Pang,K.C., Stephen,S., Dinger,M.E., Engstrom,P.G., Lenhard,B. and Mattick,J.S. (2007) RNAdb 2.0-an expanded database of mammalian non-coding RNAs. Nucleic Acids Res., 35, D178-D182.
11. Reis,E.M., Nakaya,H.I., Louro,R., Canavez,F.C., Flatschart,A.V.F., Almeida,G.T., Egidio,C.M., Paquola,A.C., Machado,A.A., Festa,F. et al. (2004) Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene, 23, 6684-6692.
12. Johnson,J.M., Edwards,S., Shoemaker,D. and Schadt,E.E. (2005) Dark matter in the genome: Evidence of widespread transcription detected by microarray tiling experiments. Trends Genet., 21, 93-102.
13. Kapranov,P., Drenkow,J., Cheng,J., Long,J., Helt,G., Dike,S. and Gingeras,T.R. (2005) Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays. Genome Res., 15, 987-997.
14. Weile,C., Gardner,P.P., Hedegaard,M.M. and Vinther,J. (2007) Use of tiling array data and RNA secondary structure predictions to identify noncoding RNA genes. BMC Genomics, 8, 244.
15. Soares,L.M.M. and Valcarcel,J. (2006) The expanding transcriptome: The genome as the 'Book of Sand'. EMBO J., 25, 923-931.
16. Seidl,C.I.M., Stricker,S.H. and Barlow,D.P. (2006) The imprinted Air ncRNA is an atypical RNAPII transcript that evades splicing and escapes nuclear export. EMBO J., 25, 3565-3575.
17. Goodrich,J.A. and Kugel,J.F. (2006) Non-coding-RNA regulators of RNA polymerase II transcription. Nat. Rev. Mol. Cell Biol., 7, 612-616.
18. Nakaya,H.I., Amaral,P.P., Louro,R., Lopes,A., Fachel,A.A., Moreira,Y.B., El Jundi,T.A., da Silva,A.M., Reis,E.M. and Verjovski-Almeida,S. (2007) Genome mapping and expression analyses of human intronic noncoding RNAs reveal tissue-specific patterns and enrichment in genes related to regulation of transcription. Genome Biol., 8, R43.
19. Mattick,J.S. (2004) RNA regulation: A new genetics? Nat. Rev. Genet. 5, 316-323.
20. Numata,K., Kanai,A., Saito,R., Kondo,S., Adachi,J., Wilming,L.G., Hume,D.A., Hayashizaki,Y. and Tomita,M. (2003) Identification of putative noncoding RNAs among the RIKEN mouse full-length cDNA collection. Genome Res., 13, 1301-1306.
21. Kampa,D., Cheng,J., Kapranov,P., Yamanaka,M., Brubaker,S., Cawley,S., Drenkow,J., Piccolboni,A., Bekiranov,S., Helt,G. et al. (2004) Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res., 14, 331-342.
22. Gustincich,S., Sandelin,A., Plessy,C., Katayama,S., Simone,R., Lazarevic,D., Hayashizaki,Y. and Carninci,P. (2006) The complexity of the mammalian transcriptome. J. Physiol., 575, 321-332.
23. Sun,H., Skogerbo,G. and Chen,R.S. (2006) Conserved distances between vertebrate highly conserved elements. Hum. Mol. Genet., 15, 2911-2922.
24. Babak,T., Blencowe,B.J. and Hughes,T.R. (2005) A systematic search for new mammalian noncoding RNAs indicates little conserved intergenic transcription. BMC Genomics, 6, 104.
25. Washietl,S., Pedersen,J.S., Korbel,J.O., Stocsits,C., Gruber,A.R., Hackermuller,J., Hertel,J., Lindemeyer,M., Reiche,K., Tanzer,A. et al. (2007) Structured RNAs in the ENCODE selected regions of the human genome. Genome Res., 17, 852-864.
26. Dias,N.E., Correa,R.G., Verjovski-Almeida,S., Briones,M.R., Nagai,M.A., da,S.W. Jr, Zago,M.A., Bordin,S., Costa,F.F., Goldman,G.H. et al. (2000) Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proc. Natl Acad. Sci. USA, 97, 3491-3496.
27. Camargo,A.A., Samaia,H.P., Dias-Neto,E., Simao,D.F., Migotto,I.A., Briones,M.R., Costa,F.F., Nagai,M.A., Verjovski-Almeida,S., Zago,M.A. et al. (2001) The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome. Proc. Natl Acad. Sci. USA, 98, 12103-12108.
28. Sironi,M., Menozzi,G., Comi,G.P., Cagliani,R., Bresolin,N. and Pozzoli,U. (2005) Analysis of intronic conserved elements indicates that functional complexity might represent a major source of negative selection on non-coding sequences. Hum. Mol. Genet., 14, 2533-2546.
29. Ravasi,T., Suzuki,H., Pang,K.C., Katayama,S., Furuno,M., Okunishi,R., Fukuda,S., Ru,K.L., Frith,M.C., Gongora,M.M. et al. (2006) Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res., 16, 11-19.
30. de Souza,S.J., Camargo,A.A., Briones,M.R., Costa,F.F., Nagai,M.A., Verjovski-Almeida,S., Zago,M.A., Andrade,L.E., Carrer,H., El Dorry,H.F. et al. (2000) Identification of human chromosome 22 transcribed sequences with ORF expressed sequence tags. Proc. Natl Acad. Sci. USA 97, 12690-12693.
31. Fonseca,R.D., Carraro,D.M. and Brentani,H. (2006) Mining ORESTES no-match database: Can we still contribute to cancer transcriptome? Genet. Mol. Res., 5, 24-32.
32. Sorek,R. and Safer,H.M. (2003) A novel algorithm for computational identification of contaminated EST libraries. Nucleic Acids Res., 31, 1067-1074.
33. Brentani,R., Carraro,D., Verjovski-Almeida,S., Reis,E., Neves,E., de Souza,S., Carvalho,A., Brentani,H. and Reis,L. (2005) Gene expression arrays in cancer research: Methods and applications. Crit. Rev. Oncol. Hematol., 54, 95-105.
34. Vangelder,R.N., Vonzastrow,M.E., Yool,A., Dement,W.C., Barchas,J.D. and Eberwine,J.H. (1990) Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl Acad. Sci. USA, 87, 1663-1667.
35. Gomes,L.I., Silva,R.L.A., Stolf,B.S., Cristo,E.B., Hirata,R., Soares,F.A., Reis,L.F.L., Neves,E.J. and Carvalho,A.F. (2003) Comparative analysis of amplified and nonamplified RNA for hybridization in cDNA microarray. Anal. Biochem., 321, 244-251.
36. DeRisi,J. (2003) In Bowtell,D. and Sambrook,J (eds.), DNA Microarrays: A Molecular Cloning Manual, Cold Spring Harbor Laboratory Press, New York, pp. 187-193.
37. Yang,Y.H. and Speed,T. (2002) Design issues for cDNA microarray experiments. Nat. Rev. Genet., 3, 579-588.
38. Yang,Y., Dudoit,S., Luu,P., Lin,D., Peng,V., Ngai,J. and Speed,T. (2002) Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res., 30, e15.
39. Kong,L., Zhang,Y., Ye,Z.Q., Liu,X.Q., Zhao,S.Q., Wei,L. and Gao,G. (2007) CPC: Assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res., 35, W345-W349.
40. Washietl,S., Hofacker,I.L. and Stadler,P.F. (2005) Fast and reliable prediction of noncoding RNAs. Proc. Natl Acad. Sci. USA, 102 2454-2459.
41. de Kok,J.B., Roelofs,R.W., Giesendorf,B.A., Pennings,J.L., Waas,E.T., Feuth,T., Swinkels,D.W. and Span,P.N. (2005) Normalization of gene expression measurements in tumor tissues: Comparison of 13 endogenous control genes. Lab. Invest., 85, 154-159.
42. Xu,J.C., Stolk,J.A., Zhang,X.Q., Silva,S.J., Houghton,R.L., Matsumura,M., Vedvick,T.S., Leslie,K.B., Badaro,R. and Reed,S.G. (2000) Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res., 60, 1677-1682.
43. Pfaffl,M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
44. Pedersen,J.S., Bejerano,G., Siepel,A., Rosenbloom,K., Lindblad-Toh,K., Lander,E.S., Kent,J., Miller,W. and Haussler,D. (2006) Identification and classification of conserved RNA secondary structures in the human genome. Plos Comput. Biol., 2, 251-262.
45. Griffiths-Jones,S. (2007) Annotating noncoding RNA genes. Annu. Rev. Genomics Hum. Genet., 8, 279-298.
46. Rymarquis,L.A., Kastenmayer,J.P., Huttenhofer,A.G. and Green,P.J. (2008) Diamonds in the rough: MRNA-like non-coding RNAs. Trends Plant Sci. 13, 329-334.
47. Liu,C., Bai,B., Skogerbo,G., Cai,L., Deng,W., Zhang,Y., Bu,D., Zhao,Y. and Chen,R. (2005) NONCODE: An integrated knowledge database of non-coding RNAs. Nucleic Acids Res., 33, D112-D115.
48. Galante,P.A.F., Vidal,D.O., de Souza,J.E., Camargo,A.A. and de Souza,S.J. (2007) Sense-antisense pairs in mammals: Functional and evolutionary considerations. Genome Biol., 8, R40.
49. Bussemakers,M.J., van Bokhoven,A., Verhaegh,G.W., Smit,F.P., Karthaus,H.F., Schalken,J.A., Debruyne,F.M., Ru,N. and Isaacs,W.B. (1999) DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res., 59, 5975-5979.
50. Jiang,Z., Woda,B.A., Wu,C.L. and Yang,X.M.J. (2004) Discovery and clinical application of a novel prostate cancer marker - alpha-Methylacyl CoA racemase (P504S). Am. J. Clin. Pathol., 122, 275-289.
51. Jiang,Z., Woda,B.A., Rock,K.L., Xu,Y.D., Savas,L., Khan,A., Pihan,G., Cai,F., Babcook,J.S., Rathanaswami,P. et al. (2001) P504S - a new molecular marker for the detection of prostate carcinoma. Am. J. Surg. Pathol., 25, 1397-1404.
52. Futreal,P., Coin,L., Marshall,M., Down,T., Hubbard,T., Wooster,R., Rahman,N. and Stratton,M. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183.
53. Griffiths-Jones,S., Moxon,S., Marshall,M., Khanna,A., Eddy,S.R. and Bateman,A. (2005) Rfam: Annotating non-coding RNAs in complete genomes. Nucleic Acids Res., 33, D121-D124.
54. Machado-Lima,A., del Portillo,H.A. and Durham,A.M. (2008) Computational methods in noncoding RNA research. J. Math. Biol., 56, 15-49.
55. Pollard,K.S., Salama,S.R., Lambert,N., Lambot,M.A., Coppens,S., Pedersen,J.S., Katzman,S., King,B., Onodera,C., Siepel,A. et al. (2006) An RNA gene expressed during cortical development evolved rapidly in humans. Nature, 443, 167-172.
56. Cooper,C.S., Campbell,C. and Jhavar,S. (2007) Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer. Nat. Clin. Pract. Urol., 4, 677-687.
57. LaTulippe,E., Satagopan,J., Smith,A., Scher,H., Scardino,P., Reuter,V. and Gerald,W.L. (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res., 62, 4499-4506.
58. Varambally,S., Dhanasekaran,S.M., Zhou,M., Barrette,T.R., Kumar-Sinha,C., Sanda,M.G., Ghosh,D., Pienta,K.J., Sewalt,R.G.A.B., Otte,A.P. et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature, 419, 624-629.
59. Rhodes,D.R., Sanda,M.G., Otte,A.P., Chinnaiyan,A.M. and Rubin,M.A. (2003) Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J. Natl Cancer Inst., 95, 661-668.
60. Tomlins,S.A., Rhodes,D.R., Perner,S., Dhanasekaran,S.M., Mehra,R., Sun,X.W., Varambally,S., Cao,X.H., Tchinda,J., Kuefer,R. et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science, 310, 644-648.
61. Reis,E.M., Ojopi,E.P.B., Alberto,F.L., Rahal,P., Tsukumo,F., Mancini,U.M., Guimaraes,G.S., Thompson,G.M.A., Camacho,C., Miracca,E. et al. (2005) Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res., 65, 1693-1699.
62. Panzitt,K., Tschernatsch,M.M.O., Guelly,C., Moustafa,T., Stradner,M., Strohmaier,H.M., Buck,C.R., Denk,H., Schroeder,R., Trauner,M. et al. (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology, 132, 330-342.
63. Brito,G.C., Fachel,A.A., Vettore,A.L., Vignal,G.M., Gimba,E.R., Campos,F.S., Barcinski,M.A., Verjovski-Almeida,S. and Reis,E.M. (2008) Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma. Mol. Carcinog., 47, 757-767.
64. Chen,W., Bocker,W., Brosius,J. and Tiedge,H. (1997) Expression of neural BC200 RNA in human tumours. J. Pathol., 183, 345-351.
65. Iacoangeli,A., Lin,Y., Morley,E.J., Muslimov,I.A., Bianchi,R., Reilly,J., Weedon,J., Diallo,R., Bocker,W. and Tiedge,H. (2004) BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis, 25, 2125-2133.
66. Ji,P., Diederichs,S., Wang,W.B., Boing,S., Metzger,R., Schneider,P.M., Tidow,N., Brandt,B., Buerger,H., Bulk,E. et al. (2003) MALAT-1, a novel noncoding RNA, and thymosin beta 4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 22, 8031-8041.
67. Srikantan,V., Zou,Z.Q., Petrovics,G., Xu,L., Augustus,M., Davis,L., Livezey,J.K., Connell,T., Sesterhenn,I.A., Yoshino,K. et al. (2000) PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl Acad. Sci. USA, 97, 12216-12221.
68. Petrovics,G., Zhang,W., Makarem,M., Street,J.P., Connelly,R., Sun,L., Sesterhenn,I.A., Srikantan,V., Moul,J.W. and Srivastava,S. (2004) Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene, 23, 605-611.
69. Schalken,J.A., Hessels,D. and Verhaegh,G. (2003) New targets for therapy in prostate cancer: Differential display code 3 (DD3(PCA3)) a highly prostate cancer-specific gene. Urology, 62, 34-43.
70. Hessels,D., Gunnewiek,J.M.T.K., van Oort,I., Karthaus,H.F.M., van Leenders,G.J.L., van Balken,B., Kiemeney,L.A., Witjes,J.A. and Schalken,J.A. (2003) DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur. Urol., 44, 8-15.
71. Tinzl,M., Marberger,M., Horvath,S. and Chypre,C. (2004) DD3(PCA3) RNA analysis in urine - a new perspective for detecting prostate cancer. Eur. Urol., 46, 182-187.
72. Lapointe,J., Li,C., Higgins,J.P., van de Rijn,M., Bair,E., Montgomery,K., Ferrari,M., Egevad,L., Rayford,W., Bergerheim,U. et al. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl Acad. Sci. USA, 101, 811-816.
73. Dhanasekaran,S.M., Barrette,T.R., Ghosh,D., Shah,R., Varambally,S., Kurachi,K., Pienta,K.J., Rubin,M.A. and Chinnaiyan,A.M. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature, 412, 822-826.
74. Kobayashi,T. and Cohen,P. (1999) Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem. J., 339 (Pt 2), 319-328.
75. Park,J., Leong,M., Buse,P., Maiyar,A., Firestone,G. and Hemmings,B. (1999) Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J., 18, 3024-3033.
76. Shanmugam,I., Cheng,G., Terranova,P., Thrasher,J., Thomas,C. and Li,B. (2007) Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival. Cell Death Differ., 14, 2085-2094.